MedTrace Logo

Predictors of Time to Viremia With an Analytic Treatment Interruption

NCT03033017 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-12-04

No results posted yet for this study

Summary

This is a two-center study of 30 HIV-infected participants who have been on antiretroviral therapy (ART) for at least two years.

Participants will be asked to undergo LN and GALT biopsies both before and after a closely monitored analytic treatment interruption (ATI).

Conditions

Interventions

OTHER

Blood Testing

Sponsors & Collaborators

Principal Investigators

  • Timothy Schacker, MD · University of Minnesota

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03033017 on ClinicalTrials.gov